(Q83979395)

English

A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy

scientific article published on 29 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hyun Cheol Chung

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hei Cheul Jeung

1

object named as

Hei-Cheul Jeung

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

7

object named as

Jae Kyung Roh

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chong Kun Cheon

3

object named as

Chong Kun Im

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

6

object named as

Woo Ick Yang

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

2050-2057

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with recurrent or metastatic gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

SPARC is associated with gastric cancer progression and poor survival of patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction between SPARC and tubulin in Xenopus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-institutional phase II study of S-1 monotherapy in advanced gastric cancer with pharmacokinetic and pharmacogenomic evaluations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical detection of the X-linked inhibitor of apoptosis protein (XIAP) in cervical squamous intraepithelial neoplasia and squamous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased antitumor activity in combined treatment TS-1 and docetaxel. A preclinical study using gastric cancer xenografts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutaneous Hand and Foot Toxicity Associated With Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of second-line chemotherapy for advanced gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25729

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25729

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523716%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83979395&oldid=2073528381"